Clal Biotechnology Industries Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
CBI
IL0011042806
Investment Holding Companies
Sales 2022 | 370K 100K 7.96M | Sales 2023 | 104K 28.16K 2.24M | Capitalization | 62.27M 16.86M 1.34B |
---|---|---|---|---|---|
Net income 2022 | -61M -16.52M -1.31B | Net income 2023 | -31M -8.39M -667M | EV / Sales 2022 | 331 x |
Net Debt 2022 | 23.85M 6.46M 513M | Net Debt 2023 | 22.4M 6.07M 482M | EV / Sales 2023 | 814 x |
P/E ratio 2022 |
-1.6
x | P/E ratio 2023 |
-2.01
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.65% |
Managers | Title | Age | Since |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 30/06/15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 08/05/03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 17/11/15 |
Gad Keren
BRD | Director/Board Member | 73 | 16/02/20 |
1st Jan change | Capi. | |
---|---|---|
+20.99% | 79.58B | |
+73.84% | 18.68B | |
+11.21% | 16.95B | |
+11.46% | 14.5B | |
+4.07% | 12.97B | |
+7.73% | 12.01B | |
+9.73% | 11.2B | |
+44.50% | 10.82B | |
-0.10% | 9.82B |